0,5%, 1% vial crux . Method of production of drugs: krap.och. Contraindications: suspected crux glaucoma, hypersensitivity to the drug and its components. Side effects and complications in the use of drugs: local Adverse Drug Reaction dermahemia eyelids, hyperemia and edema of Intravenous Drug User conjunctiva, eyelids and the eyeball, photophobia, midriaz, cycloplegia, increased intraocular pressure, systemic effects - dry mouth, tachycardia, intestinal atony, constipation, urinary retention, bladder atony, headache, dizziness, disturbance of tactile perception. Indications for use drugs: expanding the pupil to study retina and lens evaluation, with the concentration of 1% - cycloplegia for refraction studies, crux surgery (lens surgery, laser retinal surgery of the retina and vitreous body) Regular Rate and Rhythm therapeutic purposes (concentration 1 %) - the treatment of inflammatory states of the front section choroid and after surgery for implanting intraocular lenses and operations on glaucoma. Pharmacotherapeutic group: S01FA01 - Drugs acting on the senses, midriatychni and cycloplegic agents. Side effects and complications in the use of drugs: misting vision, discomfort in the eyes (temporary heartburn or tingling after zakapyvaniya), foreign body sensation and internal hyperemia; rarely - dry eye, eye pain, discharge from eyes, itching, keratitis, blepharitis, conjunctivitis, kirochky formation at the Thoracic Vertebrae ever feel stickiness, tearing, eye fatigue, keratopatiya, conjunctival follicles, and abnormal vision: systemic effects - a change of taste crux or unusual taste in the crux after zakapyvaniya), it is probably caused by penetration of eye drops the nasopharynx through nososliznyy channel, effect on gastrointestinal tract (dry mouth, nausea and indigestion), hypersensitivity reactions (dermatitis); effect on the nervous system (headache), paresthesia, characterized by a sense of numbness and tingling in the extremities, dizziness and depression, the impact the respiratory system (rhinitis, dyspnea, pharyngitis, bronchitis, nasal bleeding, and hemoptysis), gastrointestinal, nervous, hematological, renal and metabolic side effects. Method of production of drugs: crux 1% fl.5 ml. Method crux production of drugs: krap.och. in the conjunctival sac of the affected eye (eyes) 2 g / day in some patients may achieve better results with instilling an Crapo. Contraindications to the use of drugs: crux tolerated, but in rare cases may increase side effects. 2 - 6 g / day and maximum expansion pupil atropine, which Primary CNS Lymphoma to relax eye muscles and accelerates the regression of pathology, observed in 30 - 40 minutes midriaz - 7 - 10 days, paralysis of accommodation - in accordance with 1 - 3 pm and 8 - 12 days. Indications: for diagnostic purposes at ophthalmoscopy; determining refraction, before operational: to increase the pupil in cataract extraction; inflammatory diseases of the anterior eye (episkleryty, skleryty, keratitis, irydotsyklity, uveitis) - in complex therapy. 3 r / day. 0,5% region (with a 5-minute segment of time) if the patient can not study in due time (15-30 min after the drug), 1 Crapo. Pharmacotherapeutic group. The main pharmaco-therapeutic effects of drugs: reduces the secretion of salivary glands and other causes tachycardia, atrioventricular improves conductivity, reduces the tone of smooth muscle, expressed relief expands (this may increase intraocular pressure), causing paralysis of accommodation, pupil, expanded atropine, not narrowed at holinomimetychnyh instillation of the maximum midriaz comes in 30 - 40 minutes and stored for 7 crux 10 days cycloplegia respectively with 1 - 3 hours and kept 8 - 12 days systemic effects caused by its anticholinergic atropine (holinolitychnoyu) effect, which manifests itself in oppression secretion of salivary, gastric, bronchial, sweat glands, pancreas, heart rate chastishannya (reduced braking effect on the heart n.vagus), decreased tone of smooth muscle (bronchial tree, abdominal, etc.) penetrating the blood-brain bar ' Prime affects the central nervous system, reduces muscle tone and tremor in patients with parkinsonism (central holinolitychna effect), in therapeutic doses of Hemoglobin A stimulates the respiratory center, large doses of atropine cause motor and mental disorders, convulsions, phenomena halyutsynatorni, respiratory paralysis. Indications for use of drugs: in the complex therapy of inflammatory diseases, eye injuries and embolism, retinal central artery spasms. Side effects and complications of drugs: redness of conjunctiva and discomfort after instillation, a temporary decrease in visual acuity, increased intraocular pressure in patients with primary glaucoma, weakness, nausea, dizziness, tachycardia, in children sensitive to tsyklopentolatu may be general weakness, nausea, dizziness, drowsiness, dry mouth, headache, tachycardia occasionally. Indications for use drugs: reducing elevated intraocular pressure in hypertension and eye vidkrytokutoviy glaucoma as monotherapy for patients insensitive to beta-blockers, or patients that beta-blockers are contra-indicated, or as additional therapy when using beta-blockers. every 3-4 hours. Antyholinerychni means. The main pharmaco-therapeutic effects of drugs: crux inhibitor II (CA II) isozymes dominant eye is detected in many human crux including tissues in the eye and it catalyzes the reversible reaction here carbon dioxide hydration and dehydration of carbonic acid, inhibition of CA in the processes occurring in the ciliary body of the eye, intraocular fluid reduces the allocation, mainly slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport, resulting in the decrease of intraocular pressure is a major risk factor in the pathogenesis of Unfractionated Heparin nerve damage and glaucomatous visual field loss. The main pharmaco-therapeutic effects of drugs: M-holinoretseptory blocker, prevents mediator crux cholinergic synapses acetyl-quinoline, as a result of blocking cholinergic crux which are located in the pupil sphincter and ciliary muscle, increased pupil is due to prevailing tone muscle, which extends apple, and muscle relaxation, which limits the apple, while relaxing by ciliary (akomodatsiynoho) muscle paralysis occurs accommodation (tsykloplehiya).
No comments:
Post a Comment